Literature DB >> 20167181

Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.

Viswanathan Mohan1, Janarthanan Vijay Venkatraman, Rajendra Pradeepa.   

Abstract

Noncommunicable diseases, of which coronary artery disease (CAD) and diabetes top the list, have overtaken communicable diseases with respect to overall mortality, even in developing countries like India. High prevalence rates of diabetes and CAD are seen not only in affluent migrant Indians, but also in those living within the subcontinent. Indeed the epidemic of diabetes and CAD is now spreading to the middle- and lower-income groups in India. The risk for CAD is two to four times higher in diabetic subjects, and in Indians, CAD occurs prematurely, i.e., one to two decades earlier than in the West. Thus there is an urgent need for studies on CAD in diabetic and nondiabetic subjects in India. The Chennai Urban Population Study, a population-based study in Chennai, in South India, showed a prevalence of CAD of 11%, which is 10 times more than what it was in 1970. Clustering of risk factors for CAD such as hyperglycemia, central body obesity, dyslipidemia, and hypertension tends to occur, and interplay of these risk factors could explain the enhanced CAD risk in Indians. Additionally, low-grade inflammation and a possible inherent genetic susceptibility are other contributing factors. Preventive measures such as lifestyle modification with healthy diet, adequate physical activity, and decrease in stress could help prevent the twin epidemics of diabetes and CAD. 2010 Diabetes Technology Society.

Entities:  

Mesh:

Year:  2010        PMID: 20167181      PMCID: PMC2825638          DOI: 10.1177/193229681000400121

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  111 in total

1.  Cardio-metabolic burden of native asian Indian--India the global capital.

Authors:  Shashank R Joshi
Journal:  J Assoc Physicians India       Date:  2004-05

2.  Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis.

Authors:  I B Wilkinson; S A Fuchs; I M Jansen; J C Spratt; G D Murray; J R Cockcroft; D J Webb
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

3.  Association of small dense LDL with coronary artery disease and diabetes in urban Asian Indians - the Chennai Urban Rural Epidemiology Study (CURES-8).

Authors:  V Mohan; R Deepa; K Velmurugan; K Gokulakrishnan
Journal:  J Assoc Physicians India       Date:  2005-02

Review 4.  Managing the risk of atherosclerosis: the role of high-density lipoprotein.

Authors:  P Libby
Journal:  Am J Cardiol       Date:  2001-12-20       Impact factor: 2.778

5.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

Authors:  S S Anand; S Yusuf; V Vuksan; S Devanesen; K K Teo; P A Montague; L Kelemen; C Yi; E Lonn; H Gerstein; R A Hegele; M McQueen
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

6.  Physical activity and coronary heart disease in men: The Harvard Alumni Health Study.

Authors:  H D Sesso; R S Paffenbarger; I M Lee
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

7.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

8.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

9.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

10.  Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.

Authors:  M A Banerji; N Faridi; R Atluri; R L Chaiken; H E Lebovitz
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

View more
  26 in total

1.  The reference intervals for the haematological parameters in healthy adult population of chennai, southern India.

Authors:  Subhashree A R; P J Parameaswari; B Shanthi; C Revathy; B O Parijatham
Journal:  J Clin Diagn Res       Date:  2012-10-06

Review 2.  Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians.

Authors:  Pramil N Singh; Kristen N Arthur; Michael J Orlich; Wesley James; Anil Purty; Jayakaran S Job; Sujatha Rajaram; Joan Sabaté
Journal:  Am J Clin Nutr       Date:  2014-05-21       Impact factor: 7.045

Review 3.  Diabetes mellitus and its complications in India.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Nat Rev Endocrinol       Date:  2016-04-15       Impact factor: 43.330

4.  ENPP1 121Q functional variant enhances susceptibility to coronary artery disease in South Indian patients with type 2 diabetes mellitus.

Authors:  S Sumi; Surya Ramachandran; V RamanKutty; Maulin M Patel; T N Anand; Ajit S Mullasari; C C Kartha
Journal:  Mol Cell Biochem       Date:  2017-05-11       Impact factor: 3.396

5.  Public health implications of obstructive sleep apnea burden.

Authors:  Ileana Baldi; Achal Gulati; Giulia Lorenzoni; Kiran Natarajan; Simonetta Ballali; Mohan Kameswaran; Ranjith Rajeswaran; Dario Gregori; Gulshan Sethi
Journal:  Indian J Pediatr       Date:  2014-08-21       Impact factor: 1.967

6.  Comparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease - a randomized controlled trial.

Authors:  Selvarajan Sandhiya; Steven Aibor Dkhar; Ajith Ananthakrishna Pillai; Melvin George; Balachander Jayaraman; Adithan Chandrasekaran
Journal:  J Clin Diagn Res       Date:  2015-01-01

7.  Assessment of Serum VASPIN Levels among Type 2 Diabetes Mellitus Patients with or without Acute Coronary Syndrome.

Authors:  Aswathy Jaya Sathyaseelan; Prashant Shankarrao Adole; Mukta Wyawahare; Rama Prakasha Saya
Journal:  J Clin Diagn Res       Date:  2016-12-01

8.  Three-year data from the XIENCE V INDIA study: safety and efficacy of XIENCE V in 1000 real world Indian patients.

Authors:  Ashok Seth; Tejas M Patel; Marrianne Stuteville; Ravindra Kumar; Ajit S Mullasari; Upendra Kaul; Rony Mathew; A Sreenivas Kumar; Shih-Wa Ying; Krishnankutty Sudhir
Journal:  Indian Heart J       Date:  2014-04-18

9.  Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management.

Authors:  Sambit Das; A K Gupta; Biplab Bandyopadhyaya; B Harish Darla; Vivek Arya; Mahesh Abhyankar; Santosh Revankar
Journal:  Bioinformation       Date:  2021-03-31

10.  Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease.

Authors:  Maciej Bochenek; Jaroslaw Zalewski; Jerzy Sadowski; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.